<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35">
 <label>35</label>
 <element-citation publication-type="webpage">
  <collab>Food and Drug Administration (FDA)</collab>
  <source>Recommendations for investigational COVID-19 convalescent plasma</source>
  <date-in-citation content-type="access-date">Accessed 3 August 2020</date-in-citation>
  <comment>Available at: 
   <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma</ext-link>
  </comment>
 </element-citation>
</ref>
